China Universal Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,409 shares of CRSP stock, worth $830,545. This represents 0.14% of its overall portfolio holdings.
Number of Shares
15,409
Previous 15,409
-0.0%
Holding current value
$830,545
Previous $1.05 Million
-0.0%
% of portfolio
0.14%
Previous 0.13%
Shares
13 transactions
Others Institutions Holding CRSP
# of Institutions
549Shares Held
56.3MCall Options Held
2.91MPut Options Held
2.47M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.16MShares$440 Million3.97% of portfolio
-
Capital International Investors Los Angeles, CA7.84MShares$422 Million0.11% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$176 Million2.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.27MShares$176 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$146 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.2B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....